{"ticker": {"uuid": "8e4bacb1-fa21-4d58-af00-5f6157963881", "symbol": "CNMD", "name": "CONMED Corporation", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Medical Devices"}, "articles": [{"title": "CONMED (NYSE:CNMD) Downgraded by Zacks Research to Strong Sell", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxQY1c0WW14dU51UkRNU0syWUthVjA1X1VJZTI2aVBuLWJnS1A0alhZb1JLNmt4Uy03dW9FcVhacms5ekdENGdkTUNCR190dXJnSTZOWGU4bEVlLS1jb3Z0bEZpMTdEcXRyc0lSemlVTGlBNEJuQ1NXM2N5NDllSmx5N3Z6akRHLWVUVjRjRkJweHc5aW1KLTFvSDRidDZjLXRzVWRVakRhWW9zZ0ZISFVpUnpGMA?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-15T10:35:47+00:00", "published_display": "15 Jul 2026 10:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Update: Market Chatter: Conmed Shares Rise After Company Mulls Sale Amid Takeover Interest", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/market-chatter-conmed-shares-rise-150535395.html", "source_name": "MT Newswires", "published_at": "2026-07-14T15:05:35+00:00", "published_display": "14 Jul 2026 15:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Needham reiterates Hold on Conmed stock amid sale exploration By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNUlB6UUp4RTMxeHNnTXNYazJwTU1rX00wbk10Z0plSWVfVEhkT2x5SFZlc0FGWDQ4c0JDYjhIY0dxeDUxekFDSVNRbnpXcEQ3YlM4VkNwZkR5eWE1cmVQaWZaMzZBWnRIRWozYjd5NDQwRWJPWUpGVWJMRWZPUnFpS2JPRV9PZWVFVXFLUXhzUjY5cWhPbjhxbDNtaDFtSloxUEdyNHhJNnNsWGdFUkdWa3NTTHRrM0tqdTUtZjcwaw?oc=5", "source_name": "Investing.com Nigeria", "published_at": "2026-07-14T10:48:25+00:00", "published_display": "14 Jul 2026 10:48", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Needham reiterates Hold on Conmed stock amid sale exploration", "summary": "Needham has reiterated a Hold rating on Conmed (NYSE:CNMD) after reports surfaced that the medical device company is exploring a potential sale. The firm anticipates offers could come at a significant premium, citing Conmed's mid-single-digit growth, strong recurring revenue, and", "url": "https://www.investing.com/news/analyst-ratings/needham-reiterates-hold-on-conmed-stock-amid-sale-exploration-93CH-4790311", "source_name": "Investing.com", "published_at": "2026-07-14T11:03:26", "published_display": "14 Jul 2026 11:03", "sentiment": "positive", "sentiment_pct": 65, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CONMED (CNMD) Stock Trades Up, Here Is Why", "summary": "Shares of medical technology company CONMED (CNMD) jumped 9% after reports indicated the company is exploring a potential sale due to interest from private equity firms. This surge occurred despite a recent downgrade by BofA Securities due to concerns about future growth and revi", "url": "https://ca.finance.yahoo.com/news/conmed-cnmd-stock-trades-why-223039972.html", "source_name": "Yahoo! Finance Canada", "published_at": "2026-07-13T22:30:00", "published_display": "13 Jul 2026 22:30", "sentiment": "positive", "sentiment_pct": 65, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Conmed Surges Within Striking Distance Of A Breakout On Buyout Rumors", "summary": "", "url": "https://finance.yahoo.com/m/74c88e54-08c8-339f-9bfe-6a5a4202f0e3/conmed-surges-within-striking.html", "source_name": "Investor's Business Daily", "published_at": "2026-07-13T20:53:38+00:00", "published_display": "13 Jul 2026 20:53", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Market Chatter: Conmed Shares Rise After Company Mulls Sale Amid Takeover Interest", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/market-chatter-conmed-shares-rise-182708971.html", "source_name": "MT Newswires", "published_at": "2026-07-13T18:27:08+00:00", "published_display": "13 Jul 2026 18:27", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CONMED Up Over 10%, on Pace for Largest Percent Increase Since May 2025 -- Data Talk", "summary": "CONMED Corporation (CNMD) experienced a significant stock surge, rising over 10% on Monday, putting it on track for its largest percentage increase since May 2025. The stock's trading volume also substantially increased, reaching over 2 million shares, compared to its 52-week ave", "url": "https://www.moomoo.com/news/post/72869788/conmed-up-over-10-on-pace-for-largest-percent-increase?futusource=news_newspage_recommend", "source_name": "Moomoo", "published_at": "2026-07-13T16:42:20", "published_display": "13 Jul 2026 16:42", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CONMED (NYSE:CNMD) Downgraded by Wall Street Zen to Hold", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxOcEpCaHY5NndrSEZnMG5ONjhZcWJtaXk0R3BBU1c3aGFfMi1LRUVNeTRkTHVkSkVtT1owbFl1LTVBZU5wTWNlbWExVy1zUmU1YmZmUUVtemtTNThnT3pQb2RQYXdvMnB4TUNNaXZXUkFTaFdPX3ZBMzc1OWJTdlNXdHNoLTZyTWw0YXVyNGNzcHFlRWRRZldKQ1lBcWd5RjBIZnIwazhQZFIyYk0?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-12T17:11:25+00:00", "published_display": "12 Jul 2026 17:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CNMD Jumps As Conmed Weighs Sale After PE Interest", "summary": "Conmed Corp. (CNMD) is exploring strategic alternatives, including a potential sale, following private equity interest, causing its stock to jump by over 9%. While the company has solid financials and product strength in minimally invasive surgery and orthopedics, its profitabili", "url": "https://stockstotrade.com/news/conmedcorpordinaryshares-cnmd-news-2026_07_12/", "source_name": "StocksToTrade", "published_at": "2026-07-12T15:10:08", "published_display": "12 Jul 2026 15:10", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of CONMED Corporation \u2013 NYSE:CNMD", "summary": "This article provides a brief financial data point for CONMED Corporation (NYSE: CNMD), specifically its price to sales forward metric. It appears to be a stub or a section of a larger financial data platform, indicating the period and value of this financial ratio without furthe", "url": "https://www.tradingview.com/symbols/NYSE-CNMD/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-11T02:41:22", "published_display": "11 Jul 2026 02:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Conmed shares jump on potential sale report", "summary": "Shares of CONMED Corporation surged over 8% in after-hours trading after Bloomberg reported that the medical device company is exploring a potential sale. The report indicated that CONMED is evaluating its options following expressions of takeover interest.", "url": "https://www.investing.com/news/stock-market-news/conmed-shares-jump-on-potential-sale-report-93CH-4786902", "source_name": "Investing.com", "published_at": "2026-07-10T21:10:59", "published_display": "10 Jul 2026 21:10", "sentiment": "positive", "sentiment_pct": 77, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CONMED (NYSE:CNMD) Upgraded at BMO Capital Markets", "summary": "BMO Capital Markets upgraded CONMED (NYSE:CNMD) shares to a \"hold\" rating, despite a generally cautious sentiment from other analysts. The medical technology company recently reported better-than-expected quarterly results, exceeding EPS and revenue estimates, although sales saw ", "url": "https://www.marketbeat.com/instant-alerts/conmed-nysecnmd-upgraded-at-bmo-capital-markets-2026-07-10/", "source_name": "MarketBeat", "published_at": "2026-07-10T10:10:08", "published_display": "10 Jul 2026 10:10", "sentiment": "positive", "sentiment_pct": 59, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CONMED (NYSE:CNMD) Stock Price Up 11.6% - Still a Buy?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxNcE5JOE9iODZHbjlKWGY1ZkwtNklCRTZpNGlKdjdnWEFTRUtfOE96Snl0MDBVMHRLaUtrOWdVN2hLRmZoejFqNm0xTFBMZTUwOWg3S2VCWU1GQm1hMFhtUWlWRm5OT2Y4YW5Hal9TWl9RU1ZmODVOMXBvUTZqWW5iM2kxMGxRS0toanNLb0FWZWxiMkhmMmFsRVkzal9QVDg4YWc?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-09T17:22:43+00:00", "published_display": "09 Jul 2026 17:22", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CONMED stock reflects steady medical device demand amid U.S. surgery volumes", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxPa1VaU09NRUk4Zk1JM3FLNjY5Z1ByVllCUTRTS1o2ZG9VQ3RaLUpaQk1nOHgyV2c1R0tyVWNMUi1kQjhHSEp0N0JJZFViTlRFV2NQckw1M1p5RmVXWlZkamZxX0pLRTBlXzYtMGJYdV9YNVYxWjFOSE5pdnlhalpPM3dfNHBJLWtPbDFzMDN0dktlQkpUeGp3QWU1LVpnekpmSWVjUG1PeXY4YjdrNUJ5V0Vhd2JuM0pEUTcxRFgyUWZZMW1C?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-09T15:45:55+00:00", "published_display": "09 Jul 2026 15:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CNMD stock holds steady as focus shifts to the business", "summary": "CONMED Corp (CNMD) stock is holding steady, with investor focus primarily on its surgical devices business and procedure-driven demand rather than recent headlines. The company, a US-listed medical technology name, specializes in equipment for operating rooms and minimally invasi", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/cnmd-stock-holds-steady-as-focus-shifts-to-the-business/69715060", "source_name": "AD HOC NEWS", "published_at": "2026-07-07T16:31:00", "published_display": "07 Jul 2026 16:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CONMED stock centers on its medical device platform", "summary": "CONMED Corp (CNMD) is a US-listed medical technology company specializing in surgical and orthopedic devices. Its business model relies on procedure-based demand and recurring hospital use, with revenue tied to procedure volumes and hospital budgets. The stock trades on Nasdaq an", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/conmed-stock-centers-on-its-medical-device-platform/69683108", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-03T21:10:45", "published_display": "03 Jul 2026 21:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CONMED (CNMD) Stock Still Looks Cheap As Shares Fell 74%", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-03T07:00:00+00:00", "published_display": "03 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CONMED (CNMD) Stock Fair Value Moves Lower As Analysts Turn More Cautious", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxORzdGbUhoSmtzREdUajNpamh0ZkFyTG5RVlMwYnpjdTE3UWZKamxpZkIxOVdURHd2TThnS3ZSb3ZCZlQzMVhMaXBza01KTmdab0o2bUhfVGVnT1ZSWWlBcGFhOHhqOGxlTnBJbk9NUWYzZ3RoRmFaRUhuOWFvOXZVSDcxSDBHekVwNXFNNnlPWE5jUV9kdTVrVQ?oc=5", "source_name": "Market source", "published_at": "2026-07-03T07:00:00+00:00", "published_display": "03 Jul 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CONMED Corporation to Report Second Quarter 2026 Financial Results on July 29, 2026", "summary": "CONMED Corporation (NYSE: CNMD) announced that it will release its second quarter 2026 financial results after market close on Wednesday, July 29, 2026. The company will host a conference call at 4:30 p.m. ET on the same day to discuss the results. Interested parties can pre-regi", "url": "https://finance.yahoo.com/healthcare/articles/conmed-corporation-report-second-quarter-200500807.html", "source_name": "Market source", "published_at": "2026-07-03T07:05:00", "published_display": "03 Jul 2026 07:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director Jeffrey Mirviss granted 5,603 RSUs at CONMED (NYSE: CNMD)", "summary": "CONMED Corp director Jeffrey B. Mirviss was granted 5,603 restricted stock units (RSUs), which represent a contingent right to receive one share of common stock per RSU. These RSUs were awarded under the company's 2025 Long-Term Incentive Plan and are set to vest 100% after one y", "url": "https://www.stocktitan.net/sec-filings/CNMD/form-4-conmed-corp-insider-trading-activity-13488a0c90df.html", "source_name": "Stock Titan", "published_at": "2026-07-02T23:10:45", "published_display": "02 Jul 2026 23:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 CONMED Corporation For: 2 July By Investing.com", "summary": "This article announces the publication of a Form 4 for CONMED Corporation on July 2nd. The content primarily consists of navigation links and market data, with the core informational part being the Form 4 announcement itself.", "url": "https://ca.investing.com/news/stock-market-news/form-4-conmed-corporation-for-2-july-93CH-4719171", "source_name": "Investing.com Canada", "published_at": "2026-07-02T21:40:37", "published_display": "02 Jul 2026 21:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director at CONMED (CNMD) receives grant of 5,603 restricted stock units", "summary": "CONMED Corp director Celine Christine Martin was granted 5,603 restricted stock units (RSUs) as equity compensation, with each RSU representing a contingent right to receive one share of CONMED common stock. The RSUs were awarded at $0.00 per unit under the company\u2019s 2025 Long-Te", "url": "https://www.stocktitan.net/sec-filings/CNMD/form-4-conmed-corp-insider-trading-activity-09a72c697004.html", "source_name": "Stock Titan", "published_at": "2026-07-02T21:40:37", "published_display": "02 Jul 2026 21:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "New CONMED (CNMD) director Celine Christine Martin reports no common stock holdings", "summary": "CONMED Corp's new director, Celine Christine Martin, has filed an initial Form 3 reporting no direct holdings of the company's common stock. She became a director on July 1, 2026, and this filing establishes a baseline for tracking any future changes in her ownership. The Form 3 ", "url": "https://www.stocktitan.net/sec-filings/CNMD/form-3-conmed-corp-initial-statement-of-beneficial-ownership-e4bd839d034b.html", "source_name": "Stock Titan", "published_at": "2026-07-02T20:40:37", "published_display": "02 Jul 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "New CONMED (CNMD) director Jeffrey Mirviss reports no common stock holdings", "summary": "CONMED Corp director Jeffrey B. Mirviss, who joined the board on July 1, 2026, has filed an initial insider ownership report (Form 3). The filing indicates that Mirviss holds 0 shares of the company's Common Stock, thus reporting no beneficial ownership at this time. This report ", "url": "https://www.stocktitan.net/sec-filings/CNMD/form-3-conmed-corp-initial-statement-of-beneficial-ownership-d6bede1ba97c.html", "source_name": "Stock Titan", "published_at": "2026-07-02T20:40:37", "published_display": "02 Jul 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CONMED schedules Q2 results call for July 29 after market close", "summary": "CONMED Corporation (NYSE: CNMD) announced it will report its Q2 2026 financial results after the market closes on Wednesday, July 29, 2026. The company will host a conference call and webcast at 4:30 p.m. ET on the same day to discuss the results. Interested parties can pre-regis", "url": "https://www.stocktitan.net/news/CNMD/conmed-corporation-to-report-second-quarter-2026-financial-results-ca84aa3hi6u8.html", "source_name": "Stock Titan", "published_at": "2026-07-02T19:40:37", "published_display": "02 Jul 2026 19:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CNMD Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "The article provides a forecast and price target for CONMED Corporation (CNMD) stock, according to analyst opinions. It highlights the current stock price, recent performance, key financial metrics like revenue, earnings, and market capitalization, along with historical price dat", "url": "https://www.tradingview.com/symbols/NYSE-CNMD/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-07-01T13:10:20", "published_display": "01 Jul 2026 13:10", "sentiment": "negative", "sentiment_pct": 38, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why CONMED (CNMD) Shares Are Falling Today", "summary": "CONMED (NYSE:CNMD) shares fell 4.9% after BofA Securities downgraded the stock to Underperform from Neutral, citing concerns about future growth and lowering its 2027 organic growth and EPS estimates. The firm maintained a $40.00 price target. This follows an earlier drop linked ", "url": "https://ca.finance.yahoo.com/news/why-conmed-cnmd-shares-falling-221015830.html", "source_name": "Yahoo! Finance Canada", "published_at": "2026-06-29T22:09:14", "published_display": "29 Jun 2026 22:09", "sentiment": "negative", "sentiment_pct": 27, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BofA downgrades Conmed stock rating on growth concerns", "summary": "BofA Securities has downgraded Conmed (NYSE:CNMD) to Underperform from Neutral, maintaining a $40 price target due to concerns over future growth. The firm lowered its 2027 organic growth estimate to 4.5% and its 2027 earnings per share estimate to $4.54, below consensus. BofA ex", "url": "https://www.investing.com/news/analyst-ratings/bofa-downgrades-conmed-stock-rating-on-growth-concerns-93CH-4764836", "source_name": "Investing.com", "published_at": "2026-06-29T11:40:13", "published_display": "29 Jun 2026 11:40", "sentiment": "negative", "sentiment_pct": 29, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Will CONMED\u2019s New CFO Hire Reframe Its Capital Allocation Story for Investors (CNMD)?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxPUHAzNXIySV9vdmFUSEtiN1llTHU3UFVGMG9jcTZkR19GZWtZRy1xZkZ2Z0N4TF9reGRsZG9iOTgzaWNxeWpsXzc5YTgtNEFCMXo5TzNZeVRwOUJGU092Q0hVM1kxNjBZd3RpZHFSVDM5YnVsLU5jUnAtSGVWQVNOa0o5MzA3ai15RzlGTFVyWjNGOXdwVWVnS1RoSW9NWTI4N0lFRy1fdnhpcThKTThQZ2o2emhNcmF4YzVFM09YUlYwWDjSAcgBQVVfeXFMTUhnQmpaRGpfdmYyRkdBdmRzMGVDUEg3Zi1OaWYwX3NTQjlxMzNxalBSTTZBdFRlVkhXX0ZDYncwcU1EcTRnZ0JWZ1cxaU43R1pVNXU0aGhiRWtjVFQ3RDlZYjBZSENkSEl6NllIamNzS3FoNnVkdkREcXF5RWc2anFCSGZmWUtvbkJjZjFkZ041anBmTkE2MGxYTHFseUZDTUN4Q0JCTlVjRG12QkktVjFlUU0zVVcybUNabzJpZE9lQlFJQUN2R2M?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-26T07:00:00+00:00", "published_display": "26 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Conmed Corp (CNMD) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of Conmed Corp (CNMD), detailing its current price momentum score, support and resistance levels. It outlines various technical indicators like MACD, RSI, and moving averages, offering buy, sell, or neutral signals for investment referen", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-cnmd/technical", "source_name": "TradingKey", "published_at": "2026-06-23T08:10:12", "published_display": "23 Jun 2026 08:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CNMD Financials: Revenue Breakdown, Margins & Competitor Comparison", "summary": "This article provides an overview of Conmed Corp (CNMD)'s financials, detailing its revenue breakdown, profitability margins, and a comparison with competitors. General Surgery is highlighted as the largest revenue contributor, and key financial metrics like gross margin (57.86%)", "url": "https://intellectia.ai/en/stock/CNMD/financials", "source_name": "Intellectia AI", "published_at": "2026-06-22T06:39:30", "published_display": "22 Jun 2026 06:39", "sentiment": "positive", "sentiment_pct": 62, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Will CONMED\u2019s New CFO Shift CNMD\u2019s Financial Playbook Or Deepen Its Existing Strategy?", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOSFI4UENkel9FSjY1eFU4ZlRXVEFfV0lvN2pTQ0dEVEFIMWhtbHFzMThwVzVKTi0yS3hBNVFIcDRqVmRSOEdfV1RUMHg3MkUyRXVuTnRUYURodjR2WllFcV94THJGeEtjZjFMZ2Uyb3N3WjBvSUpjMmp5dTlLM1gtS1VWcEpHNVFnZjRwalhRSTJROUU4bnJ0T3JKakQ?oc=5", "source_name": "Market source", "published_at": "2026-06-21T07:00:00+00:00", "published_display": "21 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Conmed Corp (CNMD) Financial Health: Profitability & Balance Sheet Analysis", "summary": "The article provides a financial health analysis of Conmed Corp (CNMD), indicating a current financial score of 7.93, ranking 50 out of 204 in its industry. The company's financial status is weak, despite high operating efficiency, with recent quarterly revenue decreasing by 1.31", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-cnmd/financial-health", "source_name": "TradingKey", "published_at": "2026-06-18T05:39:38", "published_display": "18 Jun 2026 05:39", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Conmed Corp (CNMD) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "Conmed Corp (CNMD) has an earnings forecast score of 6.00, placing it 172nd in the Healthcare Equipment & Supplies industry. Analysts have an average target price of $52.00 for CNMD, with a \"Hold\" rating from 6 analysts. The company's expected revenue for the next quarter is $337", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-cnmd/earnings", "source_name": "TradingKey", "published_at": "2026-06-18T04:10:37", "published_display": "18 Jun 2026 04:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CONMED names John E. Gallagher as EVP & CFO, Patrick Beyer steps down as interim PFO", "summary": "CONMED has appointed John E. Gallagher as Executive Vice President and Chief Financial Officer, effective July 15, 2026. This appointment will lead to Patrick Beyer and Kimberly Lockwood ceasing their interim financial reporting officer roles. Gallagher, 53, previously served as ", "url": "https://www.tradingview.com/news/tradingview:54b4e99ee102a:0-conmed-names-john-e-gallagher-as-evp-cfo-patrick-beyer-steps-down-as-interim-pfo/", "source_name": "TradingView", "published_at": "2026-06-18T04:03:36", "published_display": "18 Jun 2026 04:03", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Conmed Corp (CNMD) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "Conmed Corp (CNMD) has distributed a total of $96.37 million in dividends over the past five years. The article provides a detailed historical timeline of upcoming and past dividend payouts, including record dates, payment dates, and ex-dividend dates for quarterly cash dividends", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-cnmd/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-17T22:10:37", "published_display": "17 Jun 2026 22:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CONMED (NYSE: CNMD) hires John Gallagher as CFO with equity-heavy pay", "summary": "CONMED Corporation has appointed John E. Gallagher as Executive Vice President and Chief Financial Officer, effective July 15, 2026. Gallagher, who brings nearly three decades of finance experience, will also serve as principal financial and principal accounting officer. His comp", "url": "https://www.stocktitan.net/sec-filings/CNMD/8-k-conmed-corp-reports-material-event-6154c31a9528.html", "source_name": "Stock Titan", "published_at": "2026-06-17T21:10:37", "published_display": "17 Jun 2026 21:10", "sentiment": "positive", "sentiment_pct": 62, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Conmed names John Gallagher as CFO effective July 15", "summary": "CONMED Corporation has announced the appointment of John E. Gallagher as its new Chief Financial Officer, effective July 15, 2026. Gallagher brings extensive financial experience from previous roles at Certara, Cue Health Inc., and Becton, Dickinson & Co. He succeeds Todd Garner,", "url": "https://www.investing.com/news/company-news/conmed-names-john-gallagher-as-cfo-effective-july-15-93CH-4748371", "source_name": "Investing.com", "published_at": "2026-06-17T21:10:37", "published_display": "17 Jun 2026 21:10", "sentiment": "positive", "sentiment_pct": 62, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Conmed Corp (CNMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article provides a detailed revenue breakdown for Conmed Corp (CNMD) for the fiscal year 2023. It categorizes revenue by business segments, namely General Surgery and Orthopedic Surgery, and by geographical regions including the United States, Europe & Middle East & Africa, ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-cnmd/revenue", "source_name": "TradingKey", "published_at": "2026-06-17T21:10:37", "published_display": "17 Jun 2026 21:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CONMED appoints John Gallagher as CFO, effective July 15 | CNMD Stock News", "summary": "CONMED Corporation (NYSE: CNMD) announced the appointment of John E. Gallagher as its new Chief Financial Officer, effective July 15, 2026. Gallagher, who brings nearly three decades of financial experience in healthcare and medical technology, succeeds Todd Garner, who will rema", "url": "https://www.stocktitan.net/news/CNMD/conmed-corporation-appoints-john-e-gallagher-as-chief-financial-c987n1vkt5go.html", "source_name": "Stock Titan", "published_at": "2026-06-17T20:10:36", "published_display": "17 Jun 2026 20:10", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNTWR3bzJReVB0UTNleWx6WDlmRW1rYmpLdkptZHdadzVERk1hTzdEV0M1Z2tuRUx2cldOT2d3WlVDank5Y01EWWFfWXdWNkJFdkNFcnhjMjdCQ1Y2aFBVbndiNXVBY0F5dDRpU2Fla25fVWRTUlNROXFwYXNXT2czUm5Nbl9QUFhFTEhHd1ZKTzJUSzhJWjN6QnNNUEVBTVEyR0l6YkZacUVsdw?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "CONMED Corporation Appoints John E. Gallagher as Chief Financial Officer", "summary": "CONMED Corporation announced the appointment of John E. Gallagher as its new Chief Financial Officer, effective July 15, 2026. Mr. Gallagher brings extensive financial leadership experience from various healthcare and industrial companies, including previous CFO roles at Certara,", "url": "https://www.businesswire.com/news/home/20260617824560/en/CONMED-Corporation-Appoints-John-E.-Gallagher-as-Chief-Financial-Officer", "source_name": "Business Wire", "published_at": "2026-06-16T02:41:22", "published_display": "16 Jun 2026 02:41", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look At CONMED (CNMD) Valuation After GI Exit, Guidance Raise And Debt Refinancing", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxPLU8wNWN5M0Ytdk5TQkNRZy12b1JzZDJtSGdFUG5QV21LUmd1WjZiYnF4dmY4a1FsNkRvb0EzRU9BSDBic2VBaHFqRk5LZjNGcW1VS3VLUUhFamRWTWRVNi13TGQ1X195OUtyTldZbVl6aUs2QUYxbTZncHFvcXpXM2pzQzdJcGxyYmgxRjFJdXBpczVrRjVHQVJXdHVMd2JqWEJ1dlhzRWVBUFoxbGU0T3FlS0lIOUJscW5NLXRLX2N2NW_SAcgBQVVfeXFMTlVNdEFraWt1N0RMX3VkWGpVc2tQbjFSRzRFVVJNZlRKbmhUNVgwNXgxbVVnUHRrLUVXSnRmVHRlV3VhUlhDWjVFMVNhajRMUHBtY0xKMmpxTXc1Nk44MTM3ZmhtWWFUX3ZEUlpVblc3S0M0dEpNZWJlYjB3YUljZzVqc1ItY3diSXRYVlp6bmphdDFYeE1PUDUzMncteXdkejRMenJ1SGdkUGdQYjQ4V2VuUWxJTFZjNFJhZ2xyYUtLZ1RBWWYzZks?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Is Conmed (CNMD) Down 3.1% Since Last Earnings Report?", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxNNExYRFZLSlBuMHhyM0o2Uk5McDVfOHM5Tl9XOGhFX0NsZkVlWTFkcHNkSXdaQktwX2M4d1Jud2o4dnVLYTJSNzNSY0VnOHRNZGctdW5mQUJDUEMyd3prdmV2ZmxzdURWMlhtNzFBX1A0M3NVLTdjeU44WC1mckNRRGJGb0dpRVhwd0g5M3pDU0I?oc=5", "source_name": "Market source", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Diversified Stocks Q1 Results: Benchmarking Stryker (NYSE:SYK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxNb1NaVXV6UW42emtDUzh5ckhKVjc2X29fSlFRRDVIVnRLWXpoWEYxUnVKNGZuLVN6ZWhxVno1SGluMEdLcmNrOGN1ZjlsWFpVRWxYbW9aYy01VFFpVzlncWtBYzF3YkJfNzhwTi1BcWlpVF9pUTU4QnNGWkJSV3YwRXVCUzk2Z2NUMWFjVkJOV2hSbFRrRnIxSWxNUGRoQmhQeDVBRjhYSnhvMDJqUThjYjBHRjhTRTBDdDZJd1k3LU5DTjU2cUx6TXFNdHhVS1FfdlFmaWZLNk41cFk?oc=5", "source_name": "StockStory", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Is CONMED Corporation (CNMD) A Good Stock To Buy Now?", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxNcWg0YWlKRGZNYnBnMXIxRF92cDBlT0tSYmZmYXBYNHJ6Y2NMWmZQNG10ODFoeXB4MDJlNVhGcWFnZGxZempCV2VkbE9XV1VacWhBNmtmODR6SWU1Qk5faDBSQk9hdzJSOGlHY0Q2LUNHbVVZd2dnekVWWVM4anA4Y3hDcWx1N1VDUmpPSzBLSXlQZENIUUZsWnpDZFNNQk9I?oc=5", "source_name": "Market source", "published_at": "2026-05-03T07:00:00+00:00", "published_display": "03 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CONMED (CNMD) Q1 Margin Compression To 4% Tests Bullish Earnings Growth Narrative", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-01T07:00:00+00:00", "published_display": "01 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical device maker CONMED cut sales but raised its 2026 forecast", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxOX01oc3N0SmxzeFd4SEJVQ0I5a1BBbzZSM0EyU2lTQjkyMjdYSUktYzY3Y29ELWVrVkxrMF9hU2xvYVJNY190MkZaSHFiNF9EX0x4T2lWMnBMYkhOVjRGN1h0TExIZ3NyTlRSOVhYS081a3AzQy1uNUJNX0szQnVMMnRHTXU4R0NoR280UktmbXZXNko3U1lHY054YWVjMGpRbUtKTW12Nk90R3B4N0c4bGd3?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Is It Time To Revisit CONMED (CNMD) After A 37% One Year Share Price Slide?", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxPak5CbllQVlctck1jdzJ1UVhWS3Z5elpTWEZPXzhSZTRZMWRSSFBHUHB3d3c4VEh5NndLZ21MOUZVajBTbnlrNmpkWmFwM0pjRjBHX2FJRkp5QmVKY0E2NHJPZFozaDRZTUV6M1lxWlVMSC1iSFpTdDBMYjhSMWJ5dGhaOFI4SkxRTjZVSUk5dllHWjRTWDZR?oc=5", "source_name": "Market source", "published_at": "2026-04-04T07:00:00+00:00", "published_display": "04 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "CONMED Refocuses Portfolio As Gastroenterology Exit And Interim CFO Shift Unfold", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-03-20T07:00:00+00:00", "published_display": "20 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Here's Why You Should Retain CONMED Stock in Your Portfolio Now", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxOQVpNSWlRRzJJSEsxV3pkZHRMQ1NGYWU0Sk5tcVRwWFR4VDkwUGMwQko3TlgwWVdsazdHaGI4Yld3MHV6dmU1Q1JXM2M2YUtXMVNadUZLM1FSaklfbEplUVlLTXdWT25EUmJSbldYVU5jU0N4dzQwMThUM3BFS1hON2hDaVVkNXlWWFhmRjZ4RWkxdHFDbkduaQ?oc=5", "source_name": "Finviz", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "CONMED (NYSE:CNMD) Downgraded by Zacks Research to Strong Sell", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxQY1c0WW14dU51UkRNU0syWUthVjA1X1VJZTI2aVBuLWJnS1A0alhZb1JLNmt4Uy03dW9FcVhacms5ekdENGdkTUNCR190dXJnSTZOWGU4bEVlLS1jb3Z0bEZpMTdEcXRyc0lSemlVTGlBNEJuQ1NXM2N5NDllSmx5N3Z6akRHLWVUVjRjRkJweHc5aW1KLTFvSDRidDZjLXRzVWRVakRhWW9zZ0ZISFVpUnpGMA?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-15T10:35:47+00:00", "published_display": "15 Jul 2026 10:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Update: Market Chatter: Conmed Shares Rise After Company Mulls Sale Amid Takeover Interest", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/market-chatter-conmed-shares-rise-150535395.html", "source_name": "MT Newswires", "published_at": "2026-07-14T15:05:35+00:00", "published_display": "14 Jul 2026 15:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Needham reiterates Hold on Conmed stock amid sale exploration By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNUlB6UUp4RTMxeHNnTXNYazJwTU1rX00wbk10Z0plSWVfVEhkT2x5SFZlc0FGWDQ4c0JDYjhIY0dxeDUxekFDSVNRbnpXcEQ3YlM4VkNwZkR5eWE1cmVQaWZaMzZBWnRIRWozYjd5NDQwRWJPWUpGVWJMRWZPUnFpS2JPRV9PZWVFVXFLUXhzUjY5cWhPbjhxbDNtaDFtSloxUEdyNHhJNnNsWGdFUkdWa3NTTHRrM0tqdTUtZjcwaw?oc=5", "source_name": "Investing.com Nigeria", "published_at": "2026-07-14T10:48:25+00:00", "published_display": "14 Jul 2026 10:48", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Needham reiterates Hold on Conmed stock amid sale exploration", "summary": "Needham has reiterated a Hold rating on Conmed (NYSE:CNMD) after reports surfaced that the medical device company is exploring a potential sale. The firm anticipates offers could come at a significant premium, citing Conmed's mid-single-digit growth, strong recurring revenue, and", "url": "https://www.investing.com/news/analyst-ratings/needham-reiterates-hold-on-conmed-stock-amid-sale-exploration-93CH-4790311", "source_name": "Investing.com", "published_at": "2026-07-14T11:03:26", "published_display": "14 Jul 2026 11:03", "sentiment": "positive", "sentiment_pct": 65, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CONMED (CNMD) Stock Trades Up, Here Is Why", "summary": "Shares of medical technology company CONMED (CNMD) jumped 9% after reports indicated the company is exploring a potential sale due to interest from private equity firms. This surge occurred despite a recent downgrade by BofA Securities due to concerns about future growth and revi", "url": "https://ca.finance.yahoo.com/news/conmed-cnmd-stock-trades-why-223039972.html", "source_name": "Yahoo! Finance Canada", "published_at": "2026-07-13T22:30:00", "published_display": "13 Jul 2026 22:30", "sentiment": "positive", "sentiment_pct": 65, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Conmed Surges Within Striking Distance Of A Breakout On Buyout Rumors", "summary": "", "url": "https://finance.yahoo.com/m/74c88e54-08c8-339f-9bfe-6a5a4202f0e3/conmed-surges-within-striking.html", "source_name": "Investor's Business Daily", "published_at": "2026-07-13T20:53:38+00:00", "published_display": "13 Jul 2026 20:53", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Market Chatter: Conmed Shares Rise After Company Mulls Sale Amid Takeover Interest", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/market-chatter-conmed-shares-rise-182708971.html", "source_name": "MT Newswires", "published_at": "2026-07-13T18:27:08+00:00", "published_display": "13 Jul 2026 18:27", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CONMED Up Over 10%, on Pace for Largest Percent Increase Since May 2025 -- Data Talk", "summary": "CONMED Corporation (CNMD) experienced a significant stock surge, rising over 10% on Monday, putting it on track for its largest percentage increase since May 2025. The stock's trading volume also substantially increased, reaching over 2 million shares, compared to its 52-week ave", "url": "https://www.moomoo.com/news/post/72869788/conmed-up-over-10-on-pace-for-largest-percent-increase?futusource=news_newspage_recommend", "source_name": "Moomoo", "published_at": "2026-07-13T16:42:20", "published_display": "13 Jul 2026 16:42", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CONMED (NYSE:CNMD) Downgraded by Wall Street Zen to Hold", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxOcEpCaHY5NndrSEZnMG5ONjhZcWJtaXk0R3BBU1c3aGFfMi1LRUVNeTRkTHVkSkVtT1owbFl1LTVBZU5wTWNlbWExVy1zUmU1YmZmUUVtemtTNThnT3pQb2RQYXdvMnB4TUNNaXZXUkFTaFdPX3ZBMzc1OWJTdlNXdHNoLTZyTWw0YXVyNGNzcHFlRWRRZldKQ1lBcWd5RjBIZnIwazhQZFIyYk0?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-12T17:11:25+00:00", "published_display": "12 Jul 2026 17:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CNMD Jumps As Conmed Weighs Sale After PE Interest", "summary": "Conmed Corp. (CNMD) is exploring strategic alternatives, including a potential sale, following private equity interest, causing its stock to jump by over 9%. While the company has solid financials and product strength in minimally invasive surgery and orthopedics, its profitabili", "url": "https://stockstotrade.com/news/conmedcorpordinaryshares-cnmd-news-2026_07_12/", "source_name": "StocksToTrade", "published_at": "2026-07-12T15:10:08", "published_display": "12 Jul 2026 15:10", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of CONMED Corporation \u2013 NYSE:CNMD", "summary": "This article provides a brief financial data point for CONMED Corporation (NYSE: CNMD), specifically its price to sales forward metric. It appears to be a stub or a section of a larger financial data platform, indicating the period and value of this financial ratio without furthe", "url": "https://www.tradingview.com/symbols/NYSE-CNMD/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-11T02:41:22", "published_display": "11 Jul 2026 02:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Conmed shares jump on potential sale report", "summary": "Shares of CONMED Corporation surged over 8% in after-hours trading after Bloomberg reported that the medical device company is exploring a potential sale. The report indicated that CONMED is evaluating its options following expressions of takeover interest.", "url": "https://www.investing.com/news/stock-market-news/conmed-shares-jump-on-potential-sale-report-93CH-4786902", "source_name": "Investing.com", "published_at": "2026-07-10T21:10:59", "published_display": "10 Jul 2026 21:10", "sentiment": "positive", "sentiment_pct": 77, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CONMED (NYSE:CNMD) Upgraded at BMO Capital Markets", "summary": "BMO Capital Markets upgraded CONMED (NYSE:CNMD) shares to a \"hold\" rating, despite a generally cautious sentiment from other analysts. The medical technology company recently reported better-than-expected quarterly results, exceeding EPS and revenue estimates, although sales saw ", "url": "https://www.marketbeat.com/instant-alerts/conmed-nysecnmd-upgraded-at-bmo-capital-markets-2026-07-10/", "source_name": "MarketBeat", "published_at": "2026-07-10T10:10:08", "published_display": "10 Jul 2026 10:10", "sentiment": "positive", "sentiment_pct": 59, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CONMED (NYSE:CNMD) Stock Price Up 11.6% - Still a Buy?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxNcE5JOE9iODZHbjlKWGY1ZkwtNklCRTZpNGlKdjdnWEFTRUtfOE96Snl0MDBVMHRLaUtrOWdVN2hLRmZoejFqNm0xTFBMZTUwOWg3S2VCWU1GQm1hMFhtUWlWRm5OT2Y4YW5Hal9TWl9RU1ZmODVOMXBvUTZqWW5iM2kxMGxRS0toanNLb0FWZWxiMkhmMmFsRVkzal9QVDg4YWc?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-09T17:22:43+00:00", "published_display": "09 Jul 2026 17:22", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CONMED stock reflects steady medical device demand amid U.S. surgery volumes", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxPa1VaU09NRUk4Zk1JM3FLNjY5Z1ByVllCUTRTS1o2ZG9VQ3RaLUpaQk1nOHgyV2c1R0tyVWNMUi1kQjhHSEp0N0JJZFViTlRFV2NQckw1M1p5RmVXWlZkamZxX0pLRTBlXzYtMGJYdV9YNVYxWjFOSE5pdnlhalpPM3dfNHBJLWtPbDFzMDN0dktlQkpUeGp3QWU1LVpnekpmSWVjUG1PeXY4YjdrNUJ5V0Vhd2JuM0pEUTcxRFgyUWZZMW1C?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-09T15:45:55+00:00", "published_display": "09 Jul 2026 15:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CNMD stock holds steady as focus shifts to the business", "summary": "CONMED Corp (CNMD) stock is holding steady, with investor focus primarily on its surgical devices business and procedure-driven demand rather than recent headlines. The company, a US-listed medical technology name, specializes in equipment for operating rooms and minimally invasi", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/cnmd-stock-holds-steady-as-focus-shifts-to-the-business/69715060", "source_name": "AD HOC NEWS", "published_at": "2026-07-07T16:31:00", "published_display": "07 Jul 2026 16:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CONMED stock centers on its medical device platform", "summary": "CONMED Corp (CNMD) is a US-listed medical technology company specializing in surgical and orthopedic devices. Its business model relies on procedure-based demand and recurring hospital use, with revenue tied to procedure volumes and hospital budgets. The stock trades on Nasdaq an", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/conmed-stock-centers-on-its-medical-device-platform/69683108", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-03T21:10:45", "published_display": "03 Jul 2026 21:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CONMED (CNMD) Stock Still Looks Cheap As Shares Fell 74%", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-03T07:00:00+00:00", "published_display": "03 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CONMED (CNMD) Stock Fair Value Moves Lower As Analysts Turn More Cautious", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxORzdGbUhoSmtzREdUajNpamh0ZkFyTG5RVlMwYnpjdTE3UWZKamxpZkIxOVdURHd2TThnS3ZSb3ZCZlQzMVhMaXBza01KTmdab0o2bUhfVGVnT1ZSWWlBcGFhOHhqOGxlTnBJbk9NUWYzZ3RoRmFaRUhuOWFvOXZVSDcxSDBHekVwNXFNNnlPWE5jUV9kdTVrVQ?oc=5", "source_name": "Market source", "published_at": "2026-07-03T07:00:00+00:00", "published_display": "03 Jul 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CONMED Corporation to Report Second Quarter 2026 Financial Results on July 29, 2026", "summary": "CONMED Corporation (NYSE: CNMD) announced that it will release its second quarter 2026 financial results after market close on Wednesday, July 29, 2026. The company will host a conference call at 4:30 p.m. ET on the same day to discuss the results. Interested parties can pre-regi", "url": "https://finance.yahoo.com/healthcare/articles/conmed-corporation-report-second-quarter-200500807.html", "source_name": "Market source", "published_at": "2026-07-03T07:05:00", "published_display": "03 Jul 2026 07:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director Jeffrey Mirviss granted 5,603 RSUs at CONMED (NYSE: CNMD)", "summary": "CONMED Corp director Jeffrey B. Mirviss was granted 5,603 restricted stock units (RSUs), which represent a contingent right to receive one share of common stock per RSU. These RSUs were awarded under the company's 2025 Long-Term Incentive Plan and are set to vest 100% after one y", "url": "https://www.stocktitan.net/sec-filings/CNMD/form-4-conmed-corp-insider-trading-activity-13488a0c90df.html", "source_name": "Stock Titan", "published_at": "2026-07-02T23:10:45", "published_display": "02 Jul 2026 23:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 CONMED Corporation For: 2 July By Investing.com", "summary": "This article announces the publication of a Form 4 for CONMED Corporation on July 2nd. The content primarily consists of navigation links and market data, with the core informational part being the Form 4 announcement itself.", "url": "https://ca.investing.com/news/stock-market-news/form-4-conmed-corporation-for-2-july-93CH-4719171", "source_name": "Investing.com Canada", "published_at": "2026-07-02T21:40:37", "published_display": "02 Jul 2026 21:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director at CONMED (CNMD) receives grant of 5,603 restricted stock units", "summary": "CONMED Corp director Celine Christine Martin was granted 5,603 restricted stock units (RSUs) as equity compensation, with each RSU representing a contingent right to receive one share of CONMED common stock. The RSUs were awarded at $0.00 per unit under the company\u2019s 2025 Long-Te", "url": "https://www.stocktitan.net/sec-filings/CNMD/form-4-conmed-corp-insider-trading-activity-09a72c697004.html", "source_name": "Stock Titan", "published_at": "2026-07-02T21:40:37", "published_display": "02 Jul 2026 21:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "New CONMED (CNMD) director Celine Christine Martin reports no common stock holdings", "summary": "CONMED Corp's new director, Celine Christine Martin, has filed an initial Form 3 reporting no direct holdings of the company's common stock. She became a director on July 1, 2026, and this filing establishes a baseline for tracking any future changes in her ownership. The Form 3 ", "url": "https://www.stocktitan.net/sec-filings/CNMD/form-3-conmed-corp-initial-statement-of-beneficial-ownership-e4bd839d034b.html", "source_name": "Stock Titan", "published_at": "2026-07-02T20:40:37", "published_display": "02 Jul 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "New CONMED (CNMD) director Jeffrey Mirviss reports no common stock holdings", "summary": "CONMED Corp director Jeffrey B. Mirviss, who joined the board on July 1, 2026, has filed an initial insider ownership report (Form 3). The filing indicates that Mirviss holds 0 shares of the company's Common Stock, thus reporting no beneficial ownership at this time. This report ", "url": "https://www.stocktitan.net/sec-filings/CNMD/form-3-conmed-corp-initial-statement-of-beneficial-ownership-d6bede1ba97c.html", "source_name": "Stock Titan", "published_at": "2026-07-02T20:40:37", "published_display": "02 Jul 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CONMED schedules Q2 results call for July 29 after market close", "summary": "CONMED Corporation (NYSE: CNMD) announced it will report its Q2 2026 financial results after the market closes on Wednesday, July 29, 2026. The company will host a conference call and webcast at 4:30 p.m. ET on the same day to discuss the results. Interested parties can pre-regis", "url": "https://www.stocktitan.net/news/CNMD/conmed-corporation-to-report-second-quarter-2026-financial-results-ca84aa3hi6u8.html", "source_name": "Stock Titan", "published_at": "2026-07-02T19:40:37", "published_display": "02 Jul 2026 19:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CNMD Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "The article provides a forecast and price target for CONMED Corporation (CNMD) stock, according to analyst opinions. It highlights the current stock price, recent performance, key financial metrics like revenue, earnings, and market capitalization, along with historical price dat", "url": "https://www.tradingview.com/symbols/NYSE-CNMD/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-07-01T13:10:20", "published_display": "01 Jul 2026 13:10", "sentiment": "negative", "sentiment_pct": 38, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why CONMED (CNMD) Shares Are Falling Today", "summary": "CONMED (NYSE:CNMD) shares fell 4.9% after BofA Securities downgraded the stock to Underperform from Neutral, citing concerns about future growth and lowering its 2027 organic growth and EPS estimates. The firm maintained a $40.00 price target. This follows an earlier drop linked ", "url": "https://ca.finance.yahoo.com/news/why-conmed-cnmd-shares-falling-221015830.html", "source_name": "Yahoo! Finance Canada", "published_at": "2026-06-29T22:09:14", "published_display": "29 Jun 2026 22:09", "sentiment": "negative", "sentiment_pct": 27, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BofA downgrades Conmed stock rating on growth concerns", "summary": "BofA Securities has downgraded Conmed (NYSE:CNMD) to Underperform from Neutral, maintaining a $40 price target due to concerns over future growth. The firm lowered its 2027 organic growth estimate to 4.5% and its 2027 earnings per share estimate to $4.54, below consensus. BofA ex", "url": "https://www.investing.com/news/analyst-ratings/bofa-downgrades-conmed-stock-rating-on-growth-concerns-93CH-4764836", "source_name": "Investing.com", "published_at": "2026-06-29T11:40:13", "published_display": "29 Jun 2026 11:40", "sentiment": "negative", "sentiment_pct": 29, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Will CONMED\u2019s New CFO Hire Reframe Its Capital Allocation Story for Investors (CNMD)?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-26T07:00:00+00:00", "published_display": "26 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Conmed Corp (CNMD) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of Conmed Corp (CNMD), detailing its current price momentum score, support and resistance levels. It outlines various technical indicators like MACD, RSI, and moving averages, offering buy, sell, or neutral signals for investment referen", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-cnmd/technical", "source_name": "TradingKey", "published_at": "2026-06-23T08:10:12", "published_display": "23 Jun 2026 08:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CNMD Financials: Revenue Breakdown, Margins & Competitor Comparison", "summary": "This article provides an overview of Conmed Corp (CNMD)'s financials, detailing its revenue breakdown, profitability margins, and a comparison with competitors. General Surgery is highlighted as the largest revenue contributor, and key financial metrics like gross margin (57.86%)", "url": "https://intellectia.ai/en/stock/CNMD/financials", "source_name": "Intellectia AI", "published_at": "2026-06-22T06:39:30", "published_display": "22 Jun 2026 06:39", "sentiment": "positive", "sentiment_pct": 62, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Will CONMED\u2019s New CFO Shift CNMD\u2019s Financial Playbook Or Deepen Its Existing Strategy?", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOSFI4UENkel9FSjY1eFU4ZlRXVEFfV0lvN2pTQ0dEVEFIMWhtbHFzMThwVzVKTi0yS3hBNVFIcDRqVmRSOEdfV1RUMHg3MkUyRXVuTnRUYURodjR2WllFcV94THJGeEtjZjFMZ2Uyb3N3WjBvSUpjMmp5dTlLM1gtS1VWcEpHNVFnZjRwalhRSTJROUU4bnJ0T3JKakQ?oc=5", "source_name": "Market source", "published_at": "2026-06-21T07:00:00+00:00", "published_display": "21 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Conmed Corp (CNMD) Financial Health: Profitability & Balance Sheet Analysis", "summary": "The article provides a financial health analysis of Conmed Corp (CNMD), indicating a current financial score of 7.93, ranking 50 out of 204 in its industry. The company's financial status is weak, despite high operating efficiency, with recent quarterly revenue decreasing by 1.31", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-cnmd/financial-health", "source_name": "TradingKey", "published_at": "2026-06-18T05:39:38", "published_display": "18 Jun 2026 05:39", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Conmed Corp (CNMD) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "Conmed Corp (CNMD) has an earnings forecast score of 6.00, placing it 172nd in the Healthcare Equipment & Supplies industry. Analysts have an average target price of $52.00 for CNMD, with a \"Hold\" rating from 6 analysts. The company's expected revenue for the next quarter is $337", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-cnmd/earnings", "source_name": "TradingKey", "published_at": "2026-06-18T04:10:37", "published_display": "18 Jun 2026 04:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CONMED names John E. Gallagher as EVP & CFO, Patrick Beyer steps down as interim PFO", "summary": "CONMED has appointed John E. Gallagher as Executive Vice President and Chief Financial Officer, effective July 15, 2026. This appointment will lead to Patrick Beyer and Kimberly Lockwood ceasing their interim financial reporting officer roles. Gallagher, 53, previously served as ", "url": "https://www.tradingview.com/news/tradingview:54b4e99ee102a:0-conmed-names-john-e-gallagher-as-evp-cfo-patrick-beyer-steps-down-as-interim-pfo/", "source_name": "TradingView", "published_at": "2026-06-18T04:03:36", "published_display": "18 Jun 2026 04:03", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Conmed Corp (CNMD) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "Conmed Corp (CNMD) has distributed a total of $96.37 million in dividends over the past five years. The article provides a detailed historical timeline of upcoming and past dividend payouts, including record dates, payment dates, and ex-dividend dates for quarterly cash dividends", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-cnmd/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-17T22:10:37", "published_display": "17 Jun 2026 22:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CONMED (NYSE: CNMD) hires John Gallagher as CFO with equity-heavy pay", "summary": "CONMED Corporation has appointed John E. Gallagher as Executive Vice President and Chief Financial Officer, effective July 15, 2026. Gallagher, who brings nearly three decades of finance experience, will also serve as principal financial and principal accounting officer. His comp", "url": "https://www.stocktitan.net/sec-filings/CNMD/8-k-conmed-corp-reports-material-event-6154c31a9528.html", "source_name": "Stock Titan", "published_at": "2026-06-17T21:10:37", "published_display": "17 Jun 2026 21:10", "sentiment": "positive", "sentiment_pct": 62, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Conmed names John Gallagher as CFO effective July 15", "summary": "CONMED Corporation has announced the appointment of John E. Gallagher as its new Chief Financial Officer, effective July 15, 2026. Gallagher brings extensive financial experience from previous roles at Certara, Cue Health Inc., and Becton, Dickinson & Co. He succeeds Todd Garner,", "url": "https://www.investing.com/news/company-news/conmed-names-john-gallagher-as-cfo-effective-july-15-93CH-4748371", "source_name": "Investing.com", "published_at": "2026-06-17T21:10:37", "published_display": "17 Jun 2026 21:10", "sentiment": "positive", "sentiment_pct": 62, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Conmed Corp (CNMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article provides a detailed revenue breakdown for Conmed Corp (CNMD) for the fiscal year 2023. It categorizes revenue by business segments, namely General Surgery and Orthopedic Surgery, and by geographical regions including the United States, Europe & Middle East & Africa, ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-cnmd/revenue", "source_name": "TradingKey", "published_at": "2026-06-17T21:10:37", "published_display": "17 Jun 2026 21:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CONMED appoints John Gallagher as CFO, effective July 15 | CNMD Stock News", "summary": "CONMED Corporation (NYSE: CNMD) announced the appointment of John E. Gallagher as its new Chief Financial Officer, effective July 15, 2026. Gallagher, who brings nearly three decades of financial experience in healthcare and medical technology, succeeds Todd Garner, who will rema", "url": "https://www.stocktitan.net/news/CNMD/conmed-corporation-appoints-john-e-gallagher-as-chief-financial-c987n1vkt5go.html", "source_name": "Stock Titan", "published_at": "2026-06-17T20:10:36", "published_display": "17 Jun 2026 20:10", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CONMED Corporation Appoints John E. Gallagher as Chief Financial Officer", "summary": "CONMED Corporation announced the appointment of John E. Gallagher as its new Chief Financial Officer, effective July 15, 2026. Mr. Gallagher brings extensive financial leadership experience from various healthcare and industrial companies, including previous CFO roles at Certara,", "url": "https://www.businesswire.com/news/home/20260617824560/en/CONMED-Corporation-Appoints-John-E.-Gallagher-as-Chief-Financial-Officer", "source_name": "Business Wire", "published_at": "2026-06-16T02:41:22", "published_display": "16 Jun 2026 02:41", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look At CONMED (CNMD) Valuation After GI Exit, Guidance Raise And Debt Refinancing", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxPLU8wNWN5M0Ytdk5TQkNRZy12b1JzZDJtSGdFUG5QV21LUmd1WjZiYnF4dmY4a1FsNkRvb0EzRU9BSDBic2VBaHFqRk5LZjNGcW1VS3VLUUhFamRWTWRVNi13TGQ1X195OUtyTldZbVl6aUs2QUYxbTZncHFvcXpXM2pzQzdJcGxyYmgxRjFJdXBpczVrRjVHQVJXdHVMd2JqWEJ1dlhzRWVBUFoxbGU0T3FlS0lIOUJscW5NLXRLX2N2NW_SAcgBQVVfeXFMTlVNdEFraWt1N0RMX3VkWGpVc2tQbjFSRzRFVVJNZlRKbmhUNVgwNXgxbVVnUHRrLUVXSnRmVHRlV3VhUlhDWjVFMVNhajRMUHBtY0xKMmpxTXc1Nk44MTM3ZmhtWWFUX3ZEUlpVblc3S0M0dEpNZWJlYjB3YUljZzVqc1ItY3diSXRYVlp6bmphdDFYeE1PUDUzMncteXdkejRMenJ1SGdkUGdQYjQ4V2VuUWxJTFZjNFJhZ2xyYUtLZ1RBWWYzZks?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Is Conmed (CNMD) Down 3.1% Since Last Earnings Report?", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxNNExYRFZLSlBuMHhyM0o2Uk5McDVfOHM5Tl9XOGhFX0NsZkVlWTFkcHNkSXdaQktwX2M4d1Jud2o4dnVLYTJSNzNSY0VnOHRNZGctdW5mQUJDUEMyd3prdmV2ZmxzdURWMlhtNzFBX1A0M3NVLTdjeU44WC1mckNRRGJGb0dpRVhwd0g5M3pDU0I?oc=5", "source_name": "Market source", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is CONMED Corporation (CNMD) A Good Stock To Buy Now?", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxNcWg0YWlKRGZNYnBnMXIxRF92cDBlT0tSYmZmYXBYNHJ6Y2NMWmZQNG10ODFoeXB4MDJlNVhGcWFnZGxZempCV2VkbE9XV1VacWhBNmtmODR6SWU1Qk5faDBSQk9hdzJSOGlHY0Q2LUNHbVVZd2dnekVWWVM4anA4Y3hDcWx1N1VDUmpPSzBLSXlQZENIUUZsWnpDZFNNQk9I?oc=5", "source_name": "Market source", "published_at": "2026-05-03T07:00:00+00:00", "published_display": "03 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CONMED (CNMD) Q1 Margin Compression To 4% Tests Bullish Earnings Growth Narrative", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-01T07:00:00+00:00", "published_display": "01 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical device maker CONMED cut sales but raised its 2026 forecast", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxOX01oc3N0SmxzeFd4SEJVQ0I5a1BBbzZSM0EyU2lTQjkyMjdYSUktYzY3Y29ELWVrVkxrMF9hU2xvYVJNY190MkZaSHFiNF9EX0x4T2lWMnBMYkhOVjRGN1h0TExIZ3NyTlRSOVhYS081a3AzQy1uNUJNX0szQnVMMnRHTXU4R0NoR280UktmbXZXNko3U1lHY054YWVjMGpRbUtKTW12Nk90R3B4N0c4bGd3?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Time To Revisit CONMED (CNMD) After A 37% One Year Share Price Slide?", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxPak5CbllQVlctck1jdzJ1UVhWS3Z5elpTWEZPXzhSZTRZMWRSSFBHUHB3d3c4VEh5NndLZ21MOUZVajBTbnlrNmpkWmFwM0pjRjBHX2FJRkp5QmVKY0E2NHJPZFozaDRZTUV6M1lxWlVMSC1iSFpTdDBMYjhSMWJ5dGhaOFI4SkxRTjZVSUk5dllHWjRTWDZR?oc=5", "source_name": "Market source", "published_at": "2026-04-04T07:00:00+00:00", "published_display": "04 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CONMED Refocuses Portfolio As Gastroenterology Exit And Interim CFO Shift Unfold", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-03-20T07:00:00+00:00", "published_display": "20 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here's Why You Should Retain CONMED Stock in Your Portfolio Now", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxOQVpNSWlRRzJJSEsxV3pkZHRMQ1NGYWU0Sk5tcVRwWFR4VDkwUGMwQko3TlgwWVdsazdHaGI4Yld3MHV6dmU1Q1JXM2M2YUtXMVNadUZLM1FSaklfbEplUVlLTXdWT25EUmJSbldYVU5jU0N4dzQwMThUM3BFS1hON2hDaVVkNXlWWFhmRjZ4RWkxdHFDbkduaQ?oc=5", "source_name": "Finviz", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNTWR3bzJReVB0UTNleWx6WDlmRW1rYmpLdkptZHdadzVERk1hTzdEV0M1Z2tuRUx2cldOT2d3WlVDank5Y01EWWFfWXdWNkJFdkNFcnhjMjdCQ1Y2aFBVbndiNXVBY0F5dDRpU2Fla25fVWRTUlNROXFwYXNXT2czUm5Nbl9QUFhFTEhHd1ZKTzJUSzhJWjN6QnNNUEVBTVEyR0l6YkZacUVsdw?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Diversified Stocks Q1 Results: Benchmarking Stryker (NYSE:SYK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxNb1NaVXV6UW42emtDUzh5ckhKVjc2X29fSlFRRDVIVnRLWXpoWEYxUnVKNGZuLVN6ZWhxVno1SGluMEdLcmNrOGN1ZjlsWFpVRWxYbW9aYy01VFFpVzlncWtBYzF3YkJfNzhwTi1BcWlpVF9pUTU4QnNGWkJSV3YwRXVCUzk2Z2NUMWFjVkJOV2hSbFRrRnIxSWxNUGRoQmhQeDVBRjhYSnhvMDJqUThjYjBHRjhTRTBDdDZJd1k3LU5DTjU2cUx6TXFNdHhVS1FfdlFmaWZLNk41cFk?oc=5", "source_name": "StockStory", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 102, "total_relevant": 65, "sentiment_summary": {"positive": 18, "negative": 6, "neutral": 41, "score": 53, "total": 65, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 79, "events": [{"event": "general", "label": "Market update", "weight": 18.15, "count": 33}, {"event": "earnings", "label": "Earnings", "weight": 11.69, "count": 24}, {"event": "analyst", "label": "Analyst action", "weight": 1.65, "count": 3}, {"event": "macro", "label": "Macro sensitivity", "weight": 1.1, "count": 2}, {"event": "capital_return", "label": "Capital return", "weight": 0.55, "count": 1}, {"event": "liquidity", "label": "Balance sheet", "weight": 0.55, "count": 1}], "positive_events": 18, "negative_events": 6}, "market_context": {"has_market_context": true, "latest_close": 38.48, "latest_week": "2026-07-10", "one_week_move": 13.7, "four_week_move": 10.7, "twelve_week_move": -1.5, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.744653, "market_dynamics_buy_signal": false, "relative_strength": -18.775449, "fair_value_gap": -41.1, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 41.2804, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+13.7% over one week, +10.7% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 61, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 14}, {"label": "Stock Titan", "count": 8}, {"label": "simplywall.st", "count": 5}, {"label": "TradingKey", "count": 5}, {"label": "MarketBeat", "count": 4}, {"label": "Investing.com", "count": 4}, {"label": "TradingView", "count": 3}, {"label": "MT Newswires", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 54}, {"label": "Industry context", "count": 11}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 33}, {"label": "Earnings", "count": 24}, {"label": "Analyst action", "count": 3}, {"label": "Macro sensitivity", "count": 2}, {"label": "Capital return", "count": 1}, {"label": "Balance sheet", "count": 1}, {"label": "Guidance", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "53/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "79/100 classification confidence."}, {"label": "Company focus", "value": "54", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+13.7% over one week, +10.7% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "CONMED (NYSE:CNMD) Downgraded by Zacks Research to Strong Sell"}], "updated_at": "2026-07-16T00:47:41.267506+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}